Marshall Wace’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Buy |
1,020,254
+262,109
| +35% | +$8.2M | 0.04% | 381 |
|
|
2025
Q1 | $25.4M | Sell |
758,145
-141,573
| -16% | -$4.75M | 0.03% | 417 |
|
|
2024
Q4 | $35.3M | Sell |
899,718
-295,762
| -25% | -$11.6M | 0.04% | 346 |
|
|
2024
Q3 | $47.1M | Sell |
1,195,480
-189,194
| -14% | -$7.45M | 0.06% | 274 |
|
|
2024
Q2 | $54M | Sell |
1,384,674
-65,668
| -5% | -$2.56M | 0.07% | 232 |
|
|
2024
Q1 | $62.4M | Sell |
1,450,342
-78,306
| -5% | -$3.37M | 0.1% | 185 |
|
|
2023
Q4 | $70.4M | Sell |
1,528,648
-625,746
| -29% | -$28.8M | 0.12% | 150 |
|
|
2023
Q3 | $73.6M | Sell |
2,154,394
-166,025
| -7% | -$5.67M | 0.15% | 126 |
|
|
2023
Q2 | $89.3M | Sell |
2,320,419
-167
| -0% | -$6.43K | 0.17% | 116 |
|
|
2023
Q1 | $83.1M | Sell |
2,320,586
-45,592
| -2% | -$1.63M | 0.18% | 114 |
|
|
2022
Q4 | $93.3M | Sell |
2,366,178
-444,917
| -16% | -$17.5M | 0.21% | 90 |
|
|
2022
Q3 | $101M | Buy |
2,811,095
+820,723
| +41% | +$29.6M | 0.22% | 78 |
|
|
2022
Q2 | $60.5M | Buy |
1,990,372
+456,314
| +30% | +$13.9M | 0.12% | 153 |
|
|
2022
Q1 | $46.9M | Buy |
1,534,058
+313,101
| +26% | +$9.57M | 0.09% | 224 |
|
|
2021
Q4 | $38.1M | Buy |
1,220,957
+1,191,154
| +3,997% | +$37.2M | 0.07% | 263 |
|
|
2021
Q3 | $456K | Buy |
29,803
+19,350
| +185% | +$296K | ﹤0.01% | 1883 |
|
|
2021
Q2 | $195K | Buy |
+10,453
| New | +$195K | ﹤0.01% | 1942 |
|
|
2020
Q4 | – | Sell |
-37,345
| Closed | -$413K | – | 2093 |
|
|
2020
Q3 | $413K | Sell |
37,345
-45,567
| -55% | -$504K | ﹤0.01% | 1248 |
|
|
2020
Q2 | $1.04M | Buy |
+82,912
| New | +$1.04M | 0.01% | 955 |
|
|
2020
Q1 | – | Sell |
-48,606
| Closed | -$637K | – | 2064 |
|
|
2019
Q4 | $637K | Buy |
+48,606
| New | +$637K | ﹤0.01% | 1050 |
|